menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Mechanisms of Neuromuscular Damage in Patients With Myasthenia Gravis

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Explore the pathophysiology of myasthenia gravis, the production of autoantibodies, and more in this video.

  • Sponsored by

  • Overview

    Myasthenia gravis is a prototypical autoantibody disease, and the complement system is one mechanism involved in the disease.1,2 Here to review the pathophysiology of myasthenia gravis, the production of autoantibodies, and the activation of the complement system by anti-acetylcholine receptor antibodies is Dr Erwin Gelfand from University of Colorado Medicine.

    References

    1. Gilhus NE, et al. Nat Rev Neurol. 2016;12(5):259-268.
    2. Conti-Fine BM, et al. J Clin Invest. 2006;116(11):2843-2854.

    The ALEXION logo is a registered trademark of Alexion Pharmaceuticals, Inc.

    US/UNB-g/0234

Schedule27 Nov 2021
Webpack App